Correlation between FEV1% Predicted and Blood Eosinophils in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
Downloads
Introduction: Chronic obstructive pulmonary disease (COPD) exacerbations are still the leading causes of mortality. Eosinophil counts were recommended in assessing the risk of exacerbations. This additional examination was preferred rather than the pulmonary function test (PFT), which was considered less precise and had vast differences. Therefore, an analysis of the correlation between the FEV1% predicted and blood eosinophil counts were needed as a reference in the diagnosis of COPD exacerbation. This study aimed to determine the correlation between FEV1% predicted and blood eosinophils counts in patients with COPD exacerbations.
Methods: This was a retrospective cross-sectional study by analyzing medical records of patients with COPD exacerbations at Dr. Soetomo General Hospital, Surabaya, from 2017 to 2018.
Results: The characteristics of patients with exacerbations of COPD consisted of 91.7% male patients. Most of them were in the age group of 61-70 years old, 58.3% were in the private sector, 75% had a high school diploma, and 41.7% had normal body mass index (BMI). The percentage of the FEV1% predicted is directly proportional to the percentage of blood eosinophils with weak and statistically insignificant strength.
Conclusion: The FEV1% predicted and blood eosinophil counts had a very weak correlation and statistically insignificant strength. Thus, it could not be used as a reference for diagnosis using one of the variables. Further research is needed with sputum eosinophils and biopsy as consideration for more accurate results.
Asai K, Hirata K. Definition of Chronic Obstructive Pulmonary Disease (COPD): Is the Latest GOLD Classification of Severity Still Valid? 2017, pp. 3–16.
Organization WH. Chronic Obstructive Pulmonary Disease (COPD). Geneva, https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) (2017, accessed 22 September 2019).
National Institute for Health and Care Excellence (NICE). Chronic Obstructive Pulmonary Disease in Over 16s: Diagnosis and Management. 2019.
National Heart, Lung and BI. COPD. Maryland, https://www.nhlbi.nih.gov/health-topics/copd (2018).
Sherwood L. Human Physiology : From Cells to Systems, http://www.dawsonera.com/depp/reader/protected/external/AbstractView/S9781473732155 (2016).
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2019 Report. 2019.
Pavord ID, Jones PW, Burgel P-R, et al. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 2016; 11 Spec Iss: 21–30.
Soriano JB, Lamprecht B, Ramírez AS, et al. Mortality Prediction in Chronic Obstructive Pulmonary Disease Comparing the GOLD 2007 and 2011 Staging Systems: A Pooled Analysis of Individual Patient Data. Lancet Respir Med 2015; 3: 443–450.
Kohansal R, Martinez-Camblor P, Agustí A, et al. The Natural History of Chronic Airflow Obstruction Revisited. Am J Respir Crit Care Med 2009; 180: 3–10.
Alberg AJ, Shopland DR, Cummings KM. The 2014 Surgeon General's Report: Commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and Updating the Evidence on the Health Consequences of Cigarette Smoking. Am J Epidemiol 2014; 179: 403–412.
Kim SJ, Lee J, Park YS, et al. Age-Related Annual Decline of Lung Function in Patients with COPD. Int J Chron Obstruct Pulmon Dis 2016; 11: 51–60.
Eisner MD, Anthonisen N, Coultas D, et al. An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2010; 182: 693–718.
Oancea C, Fira-Mladinescu O, Timar B, et al. Impact of Medical Education Program on COPD Patients: A Cohort Prospective Study. Wien Klin Wochenschr 2015; 127: 388–93.
Barnes N, Calverley PMA, Kaplan A, et al. Chronic Obstructive Pulmonary Disease and Exacerbations: Patient Insights from the Global Hidden Depths of COPD Survey. BMC Pulm Med 2013; 13: 54.
Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional Status and Long-Term Mortality in Hospitalised Patients with Chronic Obstructive Pulmonary Disease (COPD). Respir Med 2007; 101: 1954–1960.
Spelta F, Fratta Pasini AM, Cazzoletti L, et al. Body Weight and Mortality in COPD: Focus on the Obesity Paradox. Eat Weight Disord 2018; 23: 15–22.
Jo YS, Yoon H Il, Kim DK, et al. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to Predict the Risk of Exacerbation. Int J Chron Obstruct Pulmon Dis 2018; 13: 101–107.
Husebí¸ GR, Bakke PS, Aanerud M, et al. Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease--Results from the Bergen COPD Cohort Study. PLoS One 2014; 9: e109721.
Saha S, Brightling CE. Eosinophilic Airway Inflammation in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 39–47.
Zhu J, Bandi V, Qiu S, et al. Cysteinyl Leukotriene 1 Receptor Expression Associated with Bronchial Inflammation in Severe Exacerbations of COPD. Chest 2012; 142: 347–357.
Vashi MT, Willoughby JL, Quinn SJ, et al. Eosinophilic Chronic Obstructive Pulmonary Disease: Implications for Exacerbations, Readmissions, and Treatment. Am J Respir Crit Care Med 2018; 199: 110–112.
Negewo NA, McDonald VM, Baines KJ, et al. Peripheral Blood Eosinophils: A Surrogate Marker for Airway Eosinophilia in Stable COPD. Int J Chron Obstruct Pulmon Dis 2016; 11: 1495–504.
Gorska K, Krenke R, Korczynski P, et al. Eosinophilicn Airway Inflammation in Chronic Obstructive Pulmonary Disease and Asthma. J Physiol Pharmacol an Off J Polish Physiol Soc 2008; 59 Suppl 6: 261–270.
Zysman M, Deslee G, Caillaud D, et al. Relationship between Blood Eosinophils, Clinical Characteristics, and Mortality in Patients with COPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 1819–1824.
Hastie AT, Martinez FJ, Curtis JL, et al. Association of Sputum and Blood Eosinophil Concentrations with Clinical Measures of COPD Severity: An Analysis of the SPIROMICS Cohort. Lancet Respir Med 2017; 5: 956–967.
Kolsum U, Donaldson GC, Singh R, et al. Blood and Sputum Eosinophils in COPD; Relationship with Bacterial Load. Respir Res 2017; 18: 88.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (